PRINCIPIA BIOPHARMA INC. Earnings Per Share (Diluted)
PRINCIPIA BIOPHARMA INC. reported Earnings Per Share (Diluted) of $0.31 per share for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2020-08-06
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for the quarter ending 2020-06-30 was $0.31, a 10.71% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for the quarter ending 2019-12-31 was -$0.80, a 316.22% decline year-over-year.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for the quarter ending 2019-09-30 was -$0.93.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for the quarter ending 2019-06-30 was $0.28.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for fiscal 2019 was -$2.09, a 466.67% decline from fiscal 2018.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for fiscal 2018 was $0.57.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for fiscal 2017 was -$50.37.
- PRINCIPIA BIOPHARMA INC. earnings per share, diluted for fiscal 2016 was -$59.89.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.31 10-Q · filed 2020-08-06 | -$0.66 10-Q · filed 2020-08-06 | ||
| 2019-12-31 | -$0.80 10-K · filed 2020-03-10 | -$2.09 10-K · filed 2020-03-10 | ||
| 2019-09-30 | -$0.93 10-K · filed 2020-03-10 | -$0.61 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$1.21 10-Q · filed 2019-11-05 | -$0.79 derived: net income ÷ weighted average shares · filed 2020-08-06 |
| 2019-06-30 | $0.28 10-Q · filed 2020-08-06 | -$0.28 10-Q · filed 2020-08-06 | $0.11 derived: net income ÷ weighted average shares · filed 2020-08-06 | $0.47 derived: net income ÷ weighted average shares · filed 2020-08-06 |
| 2019-03-31 | -$0.57 10-K · filed 2020-03-10 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-08-06 | $0.13 derived: net income ÷ weighted average shares · filed 2020-08-06 | $0.29 derived: net income ÷ weighted average shares · filed 2020-08-06 |
| 2018-12-31 | $0.37 10-K · filed 2020-03-10 | $1.02 derived: net income ÷ weighted average shares · filed 2020-03-10 | $1.63 derived: net income ÷ weighted average shares · filed 2020-03-10 | $0.57 10-K · filed 2020-03-10 |
| 2018-09-30 | $0.00 10-K · filed 2020-03-10 | $2.24 derived: net income ÷ weighted average shares · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | $2.55 derived: net income ÷ weighted average shares · filed 2020-03-10 |
| 2018-06-30 | $0.00 10-K · filed 2020-03-10 | $0.00 10-Q · filed 2019-08-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$8.29 derived: net income ÷ weighted average shares · filed 2020-03-10 |
| 2018-03-31 | $0.00 10-K · filed 2020-03-10 | -$2.81 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$12.19 derived: net income ÷ weighted average shares · filed 2020-03-10 | |
| 2017-12-31 | -$4.55 10-K · filed 2019-03-19 | -$16.54 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$50.37 10-K · filed 2020-03-10 | |
| 2017-09-30 | -$12.26 10-K · filed 2019-03-19 | -$46.85 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$16.27 10-K · filed 2019-03-19 | |||
| 2017-03-31 | -$18.63 10-K · filed 2019-03-19 | |||
| 2016-12-31 | -$59.89 10-K · filed 2019-03-19 |